You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PNAS this week: diversity and spread of Yersinia pestis, local adaptations in switchgrass, and more.
China's State Council is strengthening regulations regarding scientific studies that rely on genetic or other material from Chinese individuals, according to Reuters.
Bio-Techne announced this week that it has agreed to acquire all of the stock of B-MoGen Biotechnologies.
Biotage will provide systems and consumables from its analytical chemistry portfolio to be sold by Yingsheng under its own brand.
In PNAS this week: plant protein engineering, Angelman syndrome, and more.
Individual stocks in the GenomeWeb Index were mostly down in May, with 21 of the 30 stocks posting losses and nine stocks recording gains.
Dubbed Automobi Molecular Diagnostics, the company will establish local manufacturing facilities and work to commercialize the Novodiag platform in China.
The project, established by the National Cancer Center of Japan, screens target genes in lung cancer to advance the development of new drugs and diagnostics.
The study showed that the Zeesan test kit and qPCR instrument could be used for near-patient HPV typing of 94 samples in 2.5 hours.
The Japan Times reports that Japan's public health insurance system will cover genetic testing for some cancer patients.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.